Market revenue in 2023 | USD 78.8 million |
Market revenue in 2030 | USD 130.7 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.61% in 2023. Horizon Databook has segmented the Italy real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
Growing investment on healthcare infrastructure by private healthcare providers and the government is expected to fuel market growth. According to the European Council, in July 2021, approved the finalized version of the Recovery and Resilience Plan (RRP).
Increased number of hospital administration respiratory disease cases, rising awareness regarding sleep apnea, developed health care infrastructure, and established emergency medical facilities across Italy are expected to fuel the market growth.
For instance, according to the WHO data published in 2020, asthma death in Italy has reached 494 total deaths and lung disease death in Italy accounted for around 32,382 total deaths. Owing to this demand for RWE increases which is expected to drive the growth of Italy's RWE market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account